• English
    English
  • Categories
  • Discussions
  • Best Of...
  • Sign In
Marvel Contest of Champions
Home› RetlawIV› Agree

RetlawIV ★

Reactions

0 Off Topic 4 Insightful 31 Disagree 49 Agree 0 Dislike 6 Like 2 Awesome 6 LOL 0 Spam 0 Abuse
  • Posts1
  • Comments49
  • Re: Variant 5 - my first post

    RetlawIVRetlawIV
    August 2020
    Just finished it using 5/65 BWCV, 6* r1 Agent Venom, 3/45 Venom, 6* r1 Dormammu and 4/55 Symbiote Supreme and I have to say it wasn't too bad. It could be done with maxed 4* champs. (View Post)
    2
  • Re: Black Widow Claire Voyant underrated?

    RetlawIVRetlawIV
    August 2020
    BWCV can also take a lot of blocked hits and heal it all the way back up with her sp2 and her utility doesn't stop at immunities, with despair she can stop regen and with buff immunity as long as you… (View Post)
    3
  • Re: Black Widow Claire Voyant underrated?

    RetlawIVRetlawIV
    August 2020
    Seatin rates her under symbiote supreme, and I’ve been reading comments and I’ve been looking on the forums for info and a lot of people put her as top 5 mystic at best and below a lot of other champ… (View Post)
    6
  • Re: Black Widow Claire Voyant underrated?

    RetlawIVRetlawIV
    August 2020
    I was gonna even say that I feel like with suicides, most people would probably use BWCV over Doom, but I unfortunately do not have doom. I do have Symbiote supreme though and I definitely find mysel… (View Post)
    1
  • Re: Math experts help me here(dual class crystal probability)

    RetlawIVRetlawIV
    August 2020
    For people having trouble understanding. Yes each time he opens a singular crystal he has a 2.22% chance of getting the single champ he wants, but if he keeps opening the likelihood of that outcome h… (View Post)
    5
Next
Avatar
  • Posts1
  • Comments49

Howdy, Stranger!

It looks like you're new here. Sign in or register to get started.

Sign In Register
Logo

© 2025 MARVEL. MARVEL CONTEST OF CHAMPIONS SOFTWARE © 2025 KABAM GAMES, INC., A NETMARBLE COMPANY. ALL RIGHTS RESERVED.

  • Privacy Policy
  • Terms of Service